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ABSTRACT 
Cholinesterase inhibitors are the class of compounds which inhibit cholinesterase enzyme. These are used as 
drugs for symptomatic treatment of Alzheimer’s disease (AD). The present study, evaluate anti-cholinesterase 
property of an aqueous extract of  Mentha longifolia leaves, which is an aromatic plant traditionally used for 
several medicinal properties. Ellman’s method was used to determine the acetylcholinesterase (AChE) enzyme 
inhibitory activity of an aqueous extracts of  Mentha longifolia leaves which showed concentration dependent 
AChE inhibition with maximum inhibition of 62.82 ± 0.005% at 25μg/ml final concentrations with IC50 value of 
8.004μg/mL. The kinetic study using Lineweaver-Burk plot of an aqueous extract of Mentha longifolia leaves 
showed mixed non-competitive mode of inhibition against AChE. The anti AChE enzyme activity exhibited by 
an aqueous extracts of Mentha longifolia leaves extracts might be used in future for symptomatic treatment of AD. 
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INTRODUCTION 
Alzheimer’s disease (AD) is the most common type of 
dementia, leads to neurodegeneration over the period 
of  time  characterized  by  loss  of  memory,  thinking 
ability,  behavioural  changes,  mutism,  akinesia, 
ideational  and  ideomotor  apraxia,  visuospatial 
disorientation and aphasia. [1-4] According to cholinergic 
hypothesis,  acetylcholinesterase  (AChE)  enzymes  are 
responsible for the catalytic hydrolysis of acetylcholine 
(ACh)  into  choline  and  acid  in  the  central  nervous 
system.  [5-6] This hypothesis suggests that by blocking 
the hydrolysis of ACh by cholinesterase (ChE) enzyme 
will  result  in  increased  concentration  of  ACh  in  the 
central nervous system leads to improved cognitive  
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functions. [5-8] ChE inhibitors are the drugs that prolong 
the existence of ACh after it is released from cholinergic 
nerve  endings  by  inhibiting  AChE.  [5]  Therefore, 
inhibition  of  AChE  devised  as  a  suitable  strategy  for 
providing  symptomatic  treatment  to  AD  as  well  as 
other  forms  of  dementia  such  as  senile  dementia, 
ataxia,  myasthenia  gravis  and  Parkinson’s  disease.  [8] 
The  synthetic  drugs  approved  by  FDA  used  in  the 
treatment  of  AD  such  as  tacrine,  rivastigmine  and 
donepezil success up to certain extent in slowing down 
neurodegeneration  in  AD  suffering  patients,  are 
associated  with  side  effects  which  includes 
disturbances  in  gastrointestinal  tract,  liver  associated 
toxicity,  aggression  and  depression.  [9]  Weekly  blood 
monitoring and expensiveness further adds limitations 
of these drugs. All these limitations prompts an urgent 
need  to  look  for  new  lead  compound  from  different 
sources  including  plant  based  natural  products,  from 
which  variety  of  phytoconstituents  were  previously 
reported for having ChEs inhibitory activities. [10] In the Shekhar et al. / Kinetics of Acetylcholinesterase Inhibition by an Aqueous Extract of Mentha…..…… 
 
Int. J. Pharm. Sci. Drug Res. October-December, 2014, Vol 6, Issue 4 (348-350)  349 
present study, Mentha longifolia leaves were selected to 
study  AChE  inhibition  and  to  explore  the  mode  of 
inhibition by kinetic study. Mentha longifolia belongs to 
Lamiaceae family. Many species of this family are rich 
source  of  various  natural  AChE  inhibitors  and 
antioxidants that could be useful in the prevention and 
treatment  of  AD.  [11]  Previous  ethnopharmacological 
study  showed  that  this  plant  can  be  used  in  the 
treatment of some of the CNS disorders. [12] 
 
MATERIALS AND METHODS 
Chemicals and Reagents   
Acetylthiocholineiodide  (ATChI),  acetylcholinesterase 
from electric eel (AChE) (EC 3.1.1.7), 5, 5- ditiobis [2-
nitrobenzoic acid] (DTNB), sodium phosphate dibasic 
and sodium phosphate monobasic (Sigma Aldrich). 
Plant Materials  
The leaves samples of plant Mentha longifolia (Voucher 
no. CS/USBT004) were collected and authenticated by 
Botanist. The voucher specimens of this plant sample 
are stored in a herbarium at USBT, GGSIP University, 
Delhi, India. 
Equipments and instruments 
96-well  plate  (Corning  Inc.  NY),  eppendorf  tubes, 
centrifuge  tubes,  tips  (Tarsons  products  Ltd.  India), 
eppendorf  tube  stand,  pipettes  (Biomate),  weighing 
balance, aluminium foil, tissue paper, ice box, blotting 
paper, vortex machine (REMI), magnetic stirrer (REMI) 
spatula, muslin cloth, spectrofluorometer (SpectraMex) 
centrifuge machine and  lyophilizer (Heto). 
Preparation of plant extract 
The  fresh  sample  of  plant  material  was  air  dried  at 
room  temperature  and  powdered  using  electric 
grinder. 2 g of sample was weighed and extracted with 
40 ml of distilled water. The sample was filtered using 
muslin  cloth,  which  was  then  freeze  dried  in 
lyophilizer. Finally, the sample was collected and kept 
in -20°C. Percentage yield of sample extract was 21.5%. 
Cholinesterase inhibitory assay 
AChE  inhibition  was  determined  by  the 
spectrophotometer  using  the  Ellman’s  method  with 
slight modification in other papers. [13-17] An assessment 
of  cholinesterase  inhibition  was  carried  out  in  flat-
bottom 96- well microtitre plates using the colorimetric 
method.  A  typical  run  consisted  of  5μl  of  AChE 
solution,  at  final  assay  concentration  of  0.08  U/ml; 
200μl of 0.1 M phosphate buffer pH 8; 5μl of DTNB at a 
final  concentration  of  0.5mM  prepared  in  0.1  M 
phosphate  buffer  pH  7  containing  0.12  M  of  sodium 
bicarbonate; and 5μl of the test extract. The final assay 
concentration used for an aqueous extract of the plant 
material was 25μg/ml. The reactants were mixed and 
pre-incubated  for  15  min  at  30°C.  The  reaction  was 
initiated  by  adding  5μl  of  ATChI  at  a  final 
concentration  of  0.5mM.  As  a  control  the  inhibitor 
solution  was  replaced  with  buffer.  The  control  was 
assayed  in  triplicate.  To  monitor  any  non-  enzymatic 
hydrolysis in the reaction mixture two blanks for each 
run were prepared in triplicate. One blank consisted of 
buffer replacing enzyme and a second blank had buffer 
replacing  substrate.  Change  in  absorbance  at  412  nm 
was  measured  on  spectrophotometer,  96  well  plate 
reader  for  a  period  of  2  min  at  25°C.The  reaction 
involved  in  this  is  enzyme  hydrolyses  the  substrate 
ATChI  resulting  in  the  product  thiocholine  which 
reacts  with  Ellman’s  reagent  (DTNB)  to  produce  2- 
nitrobenzoate-5-mercaptothiocholine  and  5-thio-2-
nitrobenzoate which can be detected. 
 
Fig  1:  Percentage  inhibition  of  AChE  activity  of  different 
concentration of an aqueous extract   of Mentha longifolia leaves. 
[The equation of the line is y=13.157ln(x) + 22.522; R2=0.9844]. 
 
Fig 2: Lineweaver-Burk plot representing the reciprocal of initial 
enzyme velocity versus the reciprocal of acetylthiocholine iodide 
(ATChI)  concentration  in  the  presence  and  absence  (control)  of 
different concentrations of an aqueous extract of Mentha longifolia 
leaves. 
 
RESULTS 
The results showed that an aqueous extract of Mentha 
longifolia  leaves  showed  concentration  dependent 
inhibition against AChE at concentration ranging from 
1.56  to  25µg/mL.  The  maximum  inhibition  of 
62.82±0.005%  was  observed  at  25µg/mL  final  assay 
concentration.  The  IC50  value  calculated  from  the 
equation  obtained  from  the  concentration  versus 
percentage inhibition curve was 8.004μg/mL (Figure 1).  
The mode of enzyme inhibition was derived from the 
Lineweaver-Burk  (LB)  plot  between  the  reciprocal  of 
substrate  concentration  on  x-axis  and  reciprocal  of 
velocity  on  y-axis.  [15-17]  The  LB  plot  of  an  aqueous 
extract of Mentha longifolia leaves showed mixed non-Shekhar et al. / Kinetics of Acetylcholinesterase Inhibition by an Aqueous Extract of Mentha…..…… 
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competitive  inhibition  kinetics  as  the  intersection  of 
lines occurred neither on x-axis or y-axis but nearby x-
axis in the second quadrant (Figure 2).  
 
DISCUSSION 
Cholinesterase  inhibitors  are  used  as  drugs  for 
symptomatic  treatment  of  AD.  The  limitations 
associated with FDA approved drugs such as tacrine, 
donepezil and rivastigmine are their side effects such as 
diarrhoea, nausea, vomiting, fatigue, insomnia, muscles 
cramps,  loss  of  appetite  and  hepatotoxicity.  [18]  This 
prompted  us  to  look  for  novel  and  safer  compounds 
from  natural  sources  which  might  have  lesser  side 
effects.  In this regard, the present study showed that 
an  aqueous  extract  of  Mentha  longifolia  leaves 
significantly inhibited AChE enzyme in a concentration 
dependent  manner.  The  mechanism  of  inhibition 
demonstrated  by  LB  plot  showed  mixed  non-
competitive mode of inhibition. The results of present 
study  is  complementary  to  the  previous  studies  that 
demonstrated  anti-cholinesterase  activity  by  an 
ethanolic  extract  of  Mentha  longifolia  but  the  mode  of 
inhibition kinetics was demonstrated for the first time 
by  our  study  using  an  aqueous  extract  of  this  plant. 
Earlier  reports  also  suggest  that  the  variety  of 
phytochemicals present in the medicinal plant extract 
also might be responsible for mixed inhibition kinetic 
behaviour.  [19]  Other  species  of  Mentha  demonstrated 
neuroprotective and neurochemical properties in vivo. 
[20] Various studies shows that AChE has beta-amyloid 
(Aβ) aggregating property which can be inhibited by 
mixed  or  non-competitive  type  of  inhibitors  due  to 
their  ability  to  bind  to  the  peripheral  anionic  site  of 
AChE,  therefore,  these  can  be  used  as  a  model 
candidate  for  inhibiting  the  AChE  induced  Aβ 
aggregation.  [21]  The  mechanism  of  inhibition  also 
revealed that the extract might compete with substrate 
for  binding  at  substrate  binding  site  of  AChE  or 
combined  with  enzyme  (AChE)  or  with  enzyme-
substrate  complex  (AChE-ATChI).  In  case  of  high 
concentration of substrate the extract may bind to the 
secondary binding site of AChE. The AChE inhibition 
kinetics  in  the  present  study  indicates  a  putative 
mechanism by which the aqueous extract may have a 
novel therapeutic potential for AD. 
In  conclusion,  an  aqueous  extract  of  Mentha  longifolia 
leaves  showed  significant  anti  acetylcholinesterase 
activity. Further studies are required to identify, isolate 
and  characterize  the  phytoconstituents  from  an 
aqueous extract to find novel molecule which might be 
useful in alleviating the symptoms associated with AD.  
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